ID   TF3C2_HUMAN             Reviewed;         911 AA.
AC   Q8WUA4; D6W557; Q16632; Q9BWI7;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2004, sequence version 2.
DT   28-JUN-2023, entry version 192.
DE   RecName: Full=General transcription factor 3C polypeptide 2;
DE   AltName: Full=TF3C-beta;
DE   AltName: Full=Transcription factor IIIC 110 kDa subunit;
DE            Short=TFIIIC 110 kDa subunit;
DE            Short=TFIIIC110;
DE   AltName: Full=Transcription factor IIIC subunit beta;
GN   Name=GTF3C2; Synonyms=KIAA0011;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 41-62; 338-354;
RP   642-654 AND 757-774, AND IDENTIFICATION OF SUBUNITS OF TFIIIC2 COMPLEX.
RX   PubMed=7729686; DOI=10.1101/gad.9.6.675;
RA   Sinn E., Wang Z., Kovelman R., Roeder R.G.;
RT   "Cloning and characterization of a TFIIIC2 subunit (TFIIIC beta) whose
RT   presence correlates with activation of RNA polymerase III-mediated
RT   transcription by adenovirus E1A expression and serum factors.";
RL   Genes Dev. 9:675-685(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y., Sato S.,
RA   Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I. The
RT   coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of
RT   randomly sampled cDNA clones from human immature myeloid cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 620-911.
RC   TISSUE=Brain;
RA   Yu W., Gibbs R.A.;
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132 AND SER-167, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63 AND THR-895, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165; SER-167; SER-871;
RP   SER-892 AND SER-893, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-167; SER-220 AND SER-892, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132; SER-167; SER-597;
RP   SER-871; THR-895 AND SER-901, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63; SER-260 AND SER-901, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: Required for RNA polymerase III-mediated transcription.
CC       Component of TFIIIC that initiates transcription complex assembly on
CC       tRNA and is required for transcription of 5S rRNA and other stable
CC       nuclear and cytoplasmic RNAs. May play a direct role in stabilizing
CC       interactions of TFIIIC2 with TFIIIC1.
CC   -!- SUBUNIT: Part of the TFIIIC subcomplex TFIIIC2, consisting of six
CC       subunits, GTF3C1, GTF3C2, GTF3C3, GTF3C4, GTF3C5 and GTF3C6.
CC   -!- INTERACTION:
CC       Q8WUA4; P42345: MTOR; NbExp=3; IntAct=EBI-1237062, EBI-359260;
CC       Q8WUA4; Q8N122: RPTOR; NbExp=3; IntAct=EBI-1237062, EBI-1567928;
CC       Q8WUA4-2; Q08AM6: VAC14; NbExp=3; IntAct=EBI-11957962, EBI-2107455;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8WUA4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WUA4-2; Sequence=VSP_010566, VSP_010567;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D13636; BAA02800.1; -; mRNA.
DR   EMBL; BT009799; AAP88801.1; -; mRNA.
DR   EMBL; CH471053; EAX00595.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00596.1; -; Genomic_DNA.
DR   EMBL; BC000212; AAH00212.1; -; mRNA.
DR   EMBL; BC020981; AAH20981.1; -; mRNA.
DR   EMBL; AF054988; AAC09349.1; -; mRNA.
DR   CCDS; CCDS1749.1; -. [Q8WUA4-1]
DR   PIR; A56465; A56465.
DR   RefSeq; NP_001030598.1; NM_001035521.2. [Q8WUA4-1]
DR   RefSeq; NP_001305838.1; NM_001318909.1. [Q8WUA4-1]
DR   RefSeq; NP_001512.1; NM_001521.3. [Q8WUA4-1]
DR   AlphaFoldDB; Q8WUA4; -.
DR   BioGRID; 109231; 186.
DR   CORUM; Q8WUA4; -.
DR   DIP; DIP-38213N; -.
DR   IntAct; Q8WUA4; 69.
DR   MINT; Q8WUA4; -.
DR   STRING; 9606.ENSP00000352536; -.
DR   GlyGen; Q8WUA4; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8WUA4; -.
DR   MetOSite; Q8WUA4; -.
DR   PhosphoSitePlus; Q8WUA4; -.
DR   SwissPalm; Q8WUA4; -.
DR   BioMuta; GTF3C2; -.
DR   DMDM; 48428661; -.
DR   EPD; Q8WUA4; -.
DR   jPOST; Q8WUA4; -.
DR   MassIVE; Q8WUA4; -.
DR   MaxQB; Q8WUA4; -.
DR   PaxDb; Q8WUA4; -.
DR   PeptideAtlas; Q8WUA4; -.
DR   ProteomicsDB; 74647; -. [Q8WUA4-1]
DR   ProteomicsDB; 74648; -. [Q8WUA4-2]
DR   Antibodypedia; 13626; 222 antibodies from 28 providers.
DR   DNASU; 2976; -.
DR   Ensembl; ENST00000264720.8; ENSP00000264720.3; ENSG00000115207.15. [Q8WUA4-1]
DR   Ensembl; ENST00000359541.6; ENSP00000352536.2; ENSG00000115207.15. [Q8WUA4-1]
DR   GeneID; 2976; -.
DR   KEGG; hsa:2976; -.
DR   MANE-Select; ENST00000264720.8; ENSP00000264720.3; NM_001035521.3; NP_001030598.1.
DR   UCSC; uc002rju.3; human. [Q8WUA4-1]
DR   AGR; HGNC:4665; -.
DR   CTD; 2976; -.
DR   DisGeNET; 2976; -.
DR   GeneCards; GTF3C2; -.
DR   HGNC; HGNC:4665; GTF3C2.
DR   HPA; ENSG00000115207; Low tissue specificity.
DR   MIM; 604883; gene.
DR   neXtProt; NX_Q8WUA4; -.
DR   OpenTargets; ENSG00000115207; -.
DR   PharmGKB; PA29053; -.
DR   VEuPathDB; HostDB:ENSG00000115207; -.
DR   eggNOG; ENOG502RAA6; Eukaryota.
DR   GeneTree; ENSGT00390000018632; -.
DR   HOGENOM; CLU_014720_0_0_1; -.
DR   InParanoid; Q8WUA4; -.
DR   OMA; DKGFIWQ; -.
DR   OrthoDB; 2919637at2759; -.
DR   PhylomeDB; Q8WUA4; -.
DR   TreeFam; TF314779; -.
DR   PathwayCommons; Q8WUA4; -.
DR   Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR   Reactome; R-HSA-76061; RNA Polymerase III Transcription Initiation From Type 1 Promoter.
DR   Reactome; R-HSA-76066; RNA Polymerase III Transcription Initiation From Type 2 Promoter.
DR   SignaLink; Q8WUA4; -.
DR   SIGNOR; Q8WUA4; -.
DR   BioGRID-ORCS; 2976; 617 hits in 1166 CRISPR screens.
DR   ChiTaRS; GTF3C2; human.
DR   GeneWiki; GTF3C2; -.
DR   GenomeRNAi; 2976; -.
DR   Pharos; Q8WUA4; Tbio.
DR   PRO; PR:Q8WUA4; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q8WUA4; protein.
DR   Bgee; ENSG00000115207; Expressed in lower esophagus mucosa and 101 other tissues.
DR   ExpressionAtlas; Q8WUA4; baseline and differential.
DR   Genevisible; Q8WUA4; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000127; C:transcription factor TFIIIC complex; IDA:HGNC-UCL.
DR   GO; GO:0000995; F:RNA polymerase III general transcription initiation factor activity; IDA:GO_Central.
DR   GO; GO:0042791; P:5S class rRNA transcription by RNA polymerase III; IC:HGNC-UCL.
DR   GO; GO:0006383; P:transcription by RNA polymerase III; IDA:HGNC-UCL.
DR   GO; GO:0042797; P:tRNA transcription by RNA polymerase III; IC:HGNC-UCL.
DR   Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 1.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR15052:SF2; GENERAL TRANSCRIPTION FACTOR 3C POLYPEPTIDE 2; 1.
DR   PANTHER; PTHR15052; RNA POLYMERASE III TRANSCRIPTION INITIATION FACTOR COMPLEX SUBUNIT; 1.
DR   Pfam; PF00400; WD40; 1.
DR   SMART; SM00320; WD40; 4.
DR   SUPFAM; SSF50978; WD40 repeat-like; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 2.
DR   PROSITE; PS50082; WD_REPEATS_2; 1.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Direct protein sequencing; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Transcription; WD repeat.
FT   CHAIN           1..911
FT                   /note="General transcription factor 3C polypeptide 2"
FT                   /id="PRO_0000050985"
FT   REPEAT          366..426
FT                   /note="WD 1"
FT   REPEAT          427..483
FT                   /note="WD 2"
FT   REPEAT          484..535
FT                   /note="WD 3"
FT   REPEAT          536..603
FT                   /note="WD 4"
FT   REPEAT          604..654
FT                   /note="WD 5"
FT   REPEAT          655..690
FT                   /note="WD 6"
FT   REGION          24..187
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          205..297
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          765..785
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          889..911
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        25..50
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        78..92
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        95..110
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        143..183
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        251..265
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        266..285
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        768..785
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         63
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         132
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         165
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         167
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         220
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         260
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         597
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         871
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         892
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         893
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         895
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         901
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         579..585
FT                   /note="MVVFWNL -> KKNQNKT (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_010566"
FT   VAR_SEQ         586..911
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_010567"
FT   CONFLICT        301
FT                   /note="N -> D (in Ref. 3; AAP88801 and 4; AAH20981)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   911 AA;  100680 MW;  B59D91DE74555192 CRC64;
     MDTCGVGYVA LGEAGPVGNM TVVDSPGQEV LNQLDVKTSS EMTSAEASVE MSLPTPLPGF
     EDSPDQRRLP PEQESLSRLE QPDLSSEMSK VSKPRASKPG RKRGGRTRKG PKRPQQPNPP
     SAPLVPGLLD QSNPLSTPMP KKRGRKSKAE LLLLKLSKDL DRPESQSPKR PPEDFETPSG
     ERPRRRAAQV ALLYLQELAE ELSTALPAPV SCPEGPKVSS PTKPKKIRQP AACPGGEEVD
     GAPRDEDFFL QVEAEDVEES EGPSESSSEP EPVVPRSTPR GSTSGKQKPH CRGMAPNGLP
     NHIMAPVWKC LHLTKDFREQ KHSYWEFAEW IPLAWKWHLL SELEAAPYLP QEEKSPLFSV
     QREGLPEDGT LYRINRFSSI TAHPERWDVS FFTGGPLWAL DWCPVPEGAG ASQYVALFSS
     PDMNETHPLS QLHSGPGLLQ LWGLGTLQQE SCPGNRAHFV YGIACDNGCI WDLKFCPSGA
     WELPGTPRKA PLLPRLGLLA LACSDGKVLL FSLPHPEALL AQQPPDAVKP AIYKVQCVAT
     LQVGSMQATD PSECGQCLSL AWMPTRPHQH LAAGYYNGMV VFWNLPTNSP LQRIRLSDGS
     LKLYPFQCFL AHDQAVRTLQ WCKANSHFLV SAGSDRKIKF WDLRRPYEPI NSIKRFLSTE
     LAWLLPYNGV TVAQDNCYAS YGLCGIHYID AGYLGFKAYF TAPRKGTVWS LSGSDWLGTI
     AAGDISGELI AAILPDMALN PINVKRPVER RFPIYKADLI PYQDSPEGPD HSSASSGVPN
     PPKARTYTET VNHHYLLFQD TDLGSFHDLL RREPMLRMQE GEGHSQLCLD RLQLEAIHKV
     RFSPNLDSYG WLVSGGQSGL VRIHFVRGLA SPLGHRMQLE SRAHFNAMFQ PSSPTRRPGF
     SPTSHRLLPT P
//
